Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01761604 · ClinicalTrials.gov registry record · NA
A Nasal Applicator for the Treatment of Trigeminal Neuralgia
A NA study, sponsored by Chicago Anesthesia Pain Specialists.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01761604 is a NA study that has completed, run by Chicago Anesthesia Pain Specialists. The registered enrollment target is 10 participants.
The verdict
NCT01761604, a NA study, has completed, sponsored by Chicago Anesthesia Pain Specialists.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The pain from Trigeminal Neuralgia (TN) imposes a substantial burden on patients in daily function and reduces quality of life. The sphenopalatine ganglion, located in the posterior part of the middle nasal turbinate, is involved in the pain associated to TN, by blocking the sphenopalatine ganglion relieves patients from the symptoms. However, methods currently in use to accomplish this are either cumbersome for the patient or invasive regarding the puncture of structures. The purpose of this study is to evaluate the efficacy of Tx360™, a new nasal applicator device, in the treatment of TN. A local anesthetic will be delivered on the ganglion area. We are expecting that this new device will provide at least the same pain relief as the previously described approaches. However, this nasal applicator is intended to be an easy and non invasive method for office use.
Interventions
- DEVICE Nasal ganglion block for TN
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2011-12 |
| Est. Completion | 2017-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01761604
The ClinicalTrials.gov registry entry for NCT01761604 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Chicago Anesthesia Pain Specialists, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nasal ganglion block for TN is the first listed.
NCT01761604 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01761604 about?
NCT01761604 is a clinical study titled "A Nasal Applicator for the Treatment of Trigeminal Neuralgia". The pain from Trigeminal Neuralgia (TN) imposes a substantial burden on patients in daily function and reduces quality of life. The sphenopalatine ganglion, located in the posterior part of the middle nasal turbinate, is involved in the pain associated to TN, by blocking the sphenopalatine ganglion ...
What is the current status of trial NCT01761604?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2011-12. Estimated completion is 2017-09.
What interventions are being tested in trial NCT01761604?
The interventions under investigation include: Nasal ganglion block for TN (DEVICE).
Who is sponsoring clinical trial NCT01761604?
This trial is sponsored by Chicago Anesthesia Pain Specialists, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.